ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 350629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 350629; 2) Community: the network communities that were significantly associated with the response to NSC 350629; 3) Molecule: the relationships between components within communities and NSC 350629; 4) MDR: the compounds that were significantly associated with the NSC 350629.

NSC Compound Enrichment Correlation
NSC 721390 2',3'-dideoxy-2',3'-didehydrothymidyl 5-nitrofurfuryl N-methyl-N-(4-chlorobutyl) phosphoramidate 0.024108502230778 0.21381089
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.024108502230778 0.26674802
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.024108502230778 0.35850481
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.024108502230778 0.26408471
NSC 732844 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-fluorobenzene 0.024108502230778 0.42347686
NSC 100071 component of Halotex 0.0241085022307781 0.66999125
NSC 135929 Null 0.0241085022307781 0.54402735
NSC 266491 Psorspermin 0.0241085022307781 0.50181761
NSC 683556 Camptothecin Derivative 0.0247979034812107 0.090686775
NSC 301457 Cycloalkannin 0.0247979034812109 0.87663651
Total:116  Current:72    [First] [Prev] [Next] [Last]